Pre-market
You're reading the free version. Trader adds the live tape and alerts. Start tracking

Price with disclosed trades

Daily closes, past year · marks sit on transaction dates, sized by value

1 trade

Disclosure transactions for Enanta Pharmaceuticals
Reporting person Filed Transaction Transaction value Source Actions
Rottinghaus Scott T. Chief Medical Officer Aug 10, 2026 2-day lag Disposition Aug 8, 2026 $19.57K Filed shares x price SEC Form 4 View filing
Rottinghaus Scott T. Chief Medical Officer
Disposition
Calculated transaction value
$19.57K 1,467 shares @ $13.34
Traded
Aug 8, 2026
Filed
Aug 10, 2026